XX Congresso Nazionale Società Italiana di ... - Salute per tutti
XX Congresso Nazionale Società Italiana di ... - Salute per tutti
XX Congresso Nazionale Società Italiana di ... - Salute per tutti
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>XX</strong> <strong>Congresso</strong> <strong>Nazionale</strong> <strong>Società</strong> <strong>Italiana</strong> <strong>di</strong> Urologia Oncologica<br />
237 - LonG-TeRM BioCHeMiCAL ConTRoL oF PRoSTATe TUMoURS FoLLoWinG STAnDARD<br />
oR HYPeR-FRACTionATeD ConFoRMAL RADiATion<br />
Riccardo Valdagni 1 , Alan E. Nahum 2 , Tiziana Rancati 1 , Tiziana Magnani, Barbara Avuzzi, Clau<strong>di</strong>o Fiorino 3<br />
1 Prostate Program, Scientific Director’s Office, Fondazione IRCCS Istituto <strong>Nazionale</strong> dei Tumori, Via Venezian 1 , Milano, Italy;<br />
2 Department of Physics, Clatterbridge Centre for Oncology, Bebington, Merseyside, UK; 3 Me<strong>di</strong>cal Physics Department,<br />
San Raffaele Scientific Institute, Milano, Italy<br />
276 - DeFininG An MRnA eXPReSSion SiGnATURe oF GLeASon GRADe<br />
Kathryn L. Penney 1,3 , Jennifer A. Sinnott 2,3 , Katja Falla 4 , Yu<strong>di</strong> Pawitan 4 , Yujin Hoshida 5 , Peter Kraft 2 ,<br />
Michelangelo Fiorentino 6 , Sven Perner 7 , Stephen Finn 6 , Stefano Calza 8 , Richard Flavin 6 , Matthew L. Freedman 9 ,<br />
Sunita Setlur 10 , Swen-Olof Andersson 11 , Neil Martin 12 , Philip W. Kantoff 9 , Jan- Erik Johansson 11 , Hans-Olov Adamia 4 ,<br />
Mark Rubin 13 , Massimo Loda 6,10 , Todd R. Golub 12 , Ove André 10 , Meir J. Stampfer 3 , Lorelei A. Mucci 3<br />
1 Department of Epidemiology and 2 Biostatistics, Harvard School of Public Health, Boston, MA USA; 3 Channing Laboratory,<br />
Department of Me<strong>di</strong>cine, Brigham and Women’s Hospital, and Harvard Me<strong>di</strong>cal School, Boston, MA USA; 4 Department of Me<strong>di</strong>cal<br />
Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 5 The Broad Institute, Cambridge, MA USA; 6 Department<br />
of Pathology, Dana-Farber Cancer Institute, Boston, MA USA; 7 Department of Pathology, University of Ulm, Ulm, Germany;<br />
8 Department of Biome<strong>di</strong>cal Sciences and Biotechnologies, University of Brescia, Brescia, Italy; 9 Department of Me<strong>di</strong>cal Oncology,<br />
Dana-Farber Cancer Institute, Boston, MA USA; 10 Department of Pathology, Brigham and Women's Hospital and Harvard Me<strong>di</strong>cal<br />
School, Boston, MA USA; 11 Department of Urology, Örebro University Hospital, Örebro, Sweden; 12 Department of Ra<strong>di</strong>ation<br />
Oncology, Harvard Ra<strong>di</strong>ation Oncology Program, Boston, MA USA; 13 Department of Pathology and Laboratory Me<strong>di</strong>cine, Weill<br />
Cornell Me<strong>di</strong>cal College, New York, NY USA; 14 Department of Pe<strong>di</strong>atric Oncology, Dana-Farber Cancer Institute, Boston, MA USA<br />
Giovedì 24 Giugno 2010<br />
Giovedì 24 Giugno 2010 ore 08.30-09.30<br />
Aula San Luca: Comunicazioni orali selezionate<br />
64 - PCA3 URine ASSAY AnD DiAGnoSiS oF PRoSTATe CAnCeR on RePeAT PRoSTATe BioPSY: eXPeRienCe on 227 CASeS<br />
S. De Luca 1 , D.F. Randone 1 , L. Bellei 2 , E. Vestita 2 , A. Volpe 3 , C. Terrone 3 , A. Bisconti 4 , D. Fontana 4 , M. Mari 5 , M. Bellina 5 ,<br />
T. Borella 6 , P. Chioso 6 , M. Vottero 7 , A. De Zan 7 , G. Cucchiarale 8 , U. Ferrando 8 , L. Squintone 9 , R. Carone 9 ,<br />
S. Lacquaniti 10 , G. Fasolis 10 , M. Cicilano 11 , A. Milillo 11 , R. Passera 12<br />
Div. Urologia: 1 Osp. Gradenigo Torino; 2 Ivrea; 5 Rivoli; 6 Biella; 7 Osp. Cottolengo Torino; 8 Cellini Torino; 9 CTO Torino; 10 Alba Clin. Univ.<br />
Urologia; 3 Novara; 4 Molinette Torino; 11 Lab. Anal. Osp. Gradenigo Torino; 12 Med. Nucl. Univ. Molinette Torino<br />
65 - PCA3 SCoRe AnD PRoSTATe CAnCeR: iS ReALLY 35 THe BeST CUT-oFF<br />
S. De Luca 1 , D.F. Randone 1 , L. Bellei 2 , E. Vestita 2 , A. Volpe 3 , C. Terrone 3 , A. Bisconti 4 , D. Fontana 4 , M. Mari 5 , M. Bellina 5 ,<br />
T. Borella 6 , P. Chioso 6 , M. Vottero 7 , A. De Zan 7 , G. Cucchiarale 8 , U. Ferrando 8 , L. Squintone 9 , R. Carone 9 ,<br />
S. Lacquaniti 10 , G. Fasolis 10 , M. Cicilano 11 , A. Milillo 11 , R. Passera 12<br />
Div. Urologia: 1 Osp. Gradenigo Torino; 2 Ivrea; 5 Rivoli; 6 Biella; 7 Osp. Cottolengo Torino; 8 Cellini Torino; 9 CTO Torino; 10 Alba Clin. Univ.<br />
Urologia: 3 Novara; 4 Molinette Torino; 11 Lab. Anal. Osp. Gradenigo Torino; 12 Med. Nucl. Univ. Molinette Torino<br />
96 - THe PReDiCTive RoLe oF Re-TURB in THe evALUATion oF T1HG BLADDeR neoPLASM PRoGReSSion RATe<br />
Roberto Giulianelli, Luca Albanesi, Francesco Attisani, Barbara Gentile, Stefano Brunori,<br />
Luca Mavilla, Francesco Pisanti, Giorgio Vincenti, Stefano Nardoni<br />
Casa <strong>di</strong> Cura Villa Tiberia, Roma<br />
148 - THe onCoGeniC PoTenTiAL oF HUMAn PoLYoMAviRUS BK in PRoSTATe CAnCeR<br />
Salciccia Stefano 1 , Alfarone Andrea¹, Cattarino Susanna¹, Mischitelli Monica 2 , Fioriti Daniela 3 ,<br />
Bellizzi Anna 2 , Anzivino Elena 2 , Barucca Valentina 2 , Colosimo Maria Teresa 2 , Sciarra Alessandro¹,<br />
Di Silverio Franco 1 , Chiarini Fernanda 2 , Pietropaolo Valeria 2<br />
1 Department of Urology, University "La Sapienza", Rome, Italy; 2 Department of Public Health Sciences, University "La Sapienza",<br />
Rome, Italy; 3 National Institute for Infectious Diseases Lazzaro Spallanzani, Rome, Italy<br />
211 - iTeM GeneRATion oF A QUALiTY oF LiFe QUeSTionnAiRe SPeCiFiC FoR iLeAL oRTHoToPiC neoBLADDeR<br />
Salvatore Siracusano 1 , Cristina Lonar<strong>di</strong> 2 , Mauro Niero 2 , Urodynamics Club of Triveneto 2 , Giuseppe Benedetto 3 ,<br />
Pierpaolo Curti 4 , Mariangela Cerruto 4 , Fabrizio Dal Moro 5 , Vincenzo Ficarra 5 , Diego Signorello 6 , Clau<strong>di</strong>o Simeone 7 ,<br />
Maurizio Brausi 8 , Stefano Ciciliato 1 , Nicoletta Lampropoulou 1 , Francesco Visalli 1<br />
1 Clinica Urologica, Università <strong>di</strong> Trieste; 2 Dipartimento <strong>di</strong> Scienze dell’Educazione, Università <strong>di</strong> Verona;<br />
3 Divisione <strong>di</strong> Urologia, Ospedale <strong>di</strong> Vicenza; 4 Clinica Urologica, Università <strong>di</strong> Verona; 5 Clinica Urologica, Università <strong>di</strong> Padova;<br />
6 Divisione <strong>di</strong> Urologia, Ospedale <strong>di</strong> Bolzano; 7 Clinica Urologica, Università <strong>di</strong> Brescia; 8 Divisione <strong>di</strong><br />
Urologia, Ospedale <strong>di</strong> Carpi (Modena)<br />
271 - URoTenSin ii ReCePToR: A neW DiAGnoSTiC MARKeR AnD THeRAPeUTiC TARGeT<br />
in HUMAn PRoSTATe ADenoCARCinoMA<br />
Michele Caraglia 1 , Monica Marra 2 , Renato Franco 3 , Alessandro Sgambato 4 , Silvia Zappavigna 2 , Gerardo Botti 3 ,<br />
Ettore Novellino 1 , Agnese Molinari 5 , Alfredo Bu<strong>di</strong>llon 6 , Matteo Ferro 7 , Paolo Grieco 6<br />
1 Department of Pharmaceutical and Toxicological Chemistry, and 7 Institute of Urology, Department of Science, Federico II<br />
University of Naples, Naples; 2 Department of Biochemistry and Biophysics, Second University of Naples, Naples; 3 Pathology Unit<br />
and 4 Ex<strong>per</strong>imental Pharmacology Unit, National Institute of Tumours, Fondazione “G. Pascale”, Naples; 5 “Giovanni <strong>XX</strong>III” Cancer<br />
Research Centre-Institute of General Pathology, Catholic University, Italy; 6 Department of Technology and Health, Italian National<br />
Institute of Health, Rome, Italy<br />
Archivio Italiano <strong>di</strong> Urologia e Andrologia 2010; 82, 2, Supplemento 1<br />
25
Change language